Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.

Brechje de Gier Merel N van KasselElisabeth A M SandersDiederik van de BeekSusan J M HahnéArie van der EndeMerijn W Bijlsma

Published in: PloS one (2019)

In conclusion, neonatal invasive GBS infection currently causes a substantial disease burden in the Netherlands. However, important evidence gaps are yet to be filled. Furthermore, cases of GBS sepsis lacking a positive blood culture may contribute considerably to this burden potentially preventable by a future GBS vaccine.

Keyphrases

risk factors
intensive care unit
emergency department
current status
biofilm formation
staphylococcus aureus
adverse drug